Overview
CTI Vascular AG is a specialized medical equipment manufacturing company founded in 2013, headquartered in Neuhausen am Rheinfall, Schaffhausen, Switzerland. This privately held company operates with a team of 11-50 employees, focusing on the design, development, and distribution of medical devices specifically for peripheral vascular therapies. The organization is committed to innovation in the medical technology sector, ensuring that its products and methodologies meet the high standards expected by large corporations while also assisting smaller entities in the medtech industry.
Core Operations
CTI Vascular AG emphasizes innovation creation, product development through approval, and manufacturing of its core products. The company's sales are conducted through direct distribution and partnerships. Additionally, the firm engages in the licensing of intellectual property (IP) and divestiture of technologies from the early stage through to obtaining CE Mark approval. Their business model is bolstered by providing consultancy services through seasoned medical device executives focusing on MEDTEC, enabling smaller companies to achieve success within this industry.
Leadership
The management team includes key figures such as:
- Jana Brandtner - VP Quality/Regulatory Vascular Therapies
- Andreas Bodmer - COO and Co-Founder
- Michael Jetter - Director of Research & Development (R&D)
Each member of the leadership team brings a wealth of experience and expertise to ensure CTI Vascular AG remains at the forefront of medical device innovation and regulatory compliance. Andreas Bodmer contributes significant operational and management expertise with his previous experience as a Director of R&D at Abbott Vascular and a Director of Packaging EMEA at Zimmer.
Market Presence and Employment
The company has a modest but focused market presence with over 240 followers on LinkedIn, highlighting its engagement with and influence within the medical equipment manufacturing community. CTI Vascular AG regularly publishes updates and opportunities, such as job openings for positions like R&D Senior Engineer, R&D Engineer, and Quality Engineer.
Industry and Innovation
CTI Vascular AG's industry focus is firmly rooted in medical equipment manufacturing, with a specialized interest in vascular therapies. The company prides itself on a robust quality system designed to accommodate the needs of large corporations while facilitating seamless technology transfer and innovation, making it an attractive partner for both existing medical technology enterprises and emerging firms in the sector.
Competitors
CTI Vascular AG faces competition from several key players within the medical technology industry, including MTD Medical Technology and Devices, Corpuls, and Conic Vascular.
MTD Medical Technology and Devices
MTD Medical Technology and Devices is a leading med-tech group with a global presence, specializing in the design and development of medical devices primarily for diabetes care and wound care. It holds significant standing due to its robust employee base and extensive global operations.
Corpuls
Corpuls, a family-owned company based in Germany, offers high-end devices for emergency and intensive care and has been innovating for over 35 years. They have introduced several pioneering technologies, particularly in defibrillation and patient monitoring systems, upholding high-quality standards and receiving multiple industry awards.
Conic Vascular
Conic Vascular is engaged in the development and manufacture of medical devices in the cardiology and radiology fields, emphasizing PTCA technologies. The company competes directly with larger entities by focusing on specialized products designed for niche markets.
Market Position and Strategic Emphasis
CTI Vascular AG's strategic approach is bolstered by its dedication to pioneering vascular therapies and leveraging Swiss med-tech innovation standards. The company emphasizes innovation, regulatory compliance, and manufacturing quality, allowing it to effectively compete in the global market against larger firms with more extensive product lines. Through strategic partnerships and a keen focus on advancing technology, CTI Vascular AG aims to maintain its competitive edge in the dynamic med-tech landscape.
